ロード中...
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
Worldwide, rivaroxaban is increasingly used for stroke prevention in atrial fibrillation and treatment of venous thromboembolism, but little is known about rivaroxaban-related bleeding complications in daily care. Using data from a prospective, noninterventional oral anticoagulation registry of dail...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4126334/ https://ncbi.nlm.nih.gov/pubmed/24859362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-03-563577 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|